Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (191-200 of 450) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor TrametinibAnne Berberich, Tobias Kessler, Carina M Thomé, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2021
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroupFelix K F Kommoss, Damian Stichel, Jaume Mora, et al.
Acta Neuropathologica|July 26, 2023
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomasLeon D Kaulen, Evgeniya Denisova, Felix Hinz, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Oncotarget|February 17, 2015
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastomaTobias Kessler, Felix Sahm, Jonas Blaes, et al.
Plos One|March 20, 2015
Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histologyDaniel Paech, Sina Burth, Johannes Windschuh, et al.
Neuro-Oncology Advances|October 5, 2022
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cellsKevin Hai-Ning Lu, Julius Michel, Michael Kilian, et al.
Neuro-Oncology Advances|July 10, 2020
Molecular profiling-based decision for targeted therapies in <i>IDH</i> wild-type glioblastomaTobias Kessler, Anne Berberich, Belen Casalini, et al.
Nature|October 7, 2011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptorChristiane A Opitz, Ulrike M Litzenburger, Felix Sahm, et al.
Acta Neuropathologica|October 19, 2023
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042Sybren L N Maas, Philipp Sievers, Damien C Weber, et al.
Pageof 45

Showing results (191-200 of 450) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor TrametinibAnne Berberich, Tobias Kessler, Carina M Thomé, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2021
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroupFelix K F Kommoss, Damian Stichel, Jaume Mora, et al.
Acta Neuropathologica|July 26, 2023
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomasLeon D Kaulen, Evgeniya Denisova, Felix Hinz, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Oncotarget|February 17, 2015
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastomaTobias Kessler, Felix Sahm, Jonas Blaes, et al.
Plos One|March 20, 2015
Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histologyDaniel Paech, Sina Burth, Johannes Windschuh, et al.
Neuro-Oncology Advances|October 5, 2022
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cellsKevin Hai-Ning Lu, Julius Michel, Michael Kilian, et al.
Neuro-Oncology Advances|July 10, 2020
Molecular profiling-based decision for targeted therapies in <i>IDH</i> wild-type glioblastomaTobias Kessler, Anne Berberich, Belen Casalini, et al.
Nature|October 7, 2011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptorChristiane A Opitz, Ulrike M Litzenburger, Felix Sahm, et al.
Acta Neuropathologica|October 19, 2023
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042Sybren L N Maas, Philipp Sievers, Damien C Weber, et al.
Pageof 45